C9orf72: A Key Genetic Factor in ALS and Frontotemporal Dementia

Explore the C9orf72 gene, its role in neurodegeneration, associated diseases, expression patterns, and mutation mechanisms.

Gene Information Card

Symbol C9orf72
Full Name Chromosome 9 open reading frame 72
Gene Type Protein coding
Chromosomal Location 9p21.2
NCBI Gene ID 203228 ncbi.nlm.nih.gov/gene/203228
Ensembl ID ENSG00000147894
UniProt ID Q96LT7
OMIM ID 614260
HGNC ID 28337
Aliases ALSFTD, FTDALS, FLJ31684

Description

The C9orf72 gene encodes a protein of unknown function, but it is highly conserved and expressed in various tissues. A hexanucleotide repeat expansion (GGGGCC) in the first intron or promoter region is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This expansion leads to both loss-of-function and gain-of-function mechanisms, contributing to neurodegeneration.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Amyotrophic Lateral Sclerosis (ALS) Hexanucleotide repeat expansion leads to loss of C9orf72 protein and gain of toxic RNA and dipeptide repeat proteins, causing motor neuron degeneration. OMIM: 614260; ClinVar: pathogenic/likely pathogenic variants
Frontotemporal Dementia (FTD) Same repeat expansion mechanism as ALS, leading to neuronal loss in frontal and temporal lobes. OMIM: 614260; ClinVar: pathogenic/likely pathogenic variants
Frontotemporal Dementia with ALS (FTD-ALS) Overlap syndrome with both ALS and FTD features, often due to C9orf72 repeat expansion. OMIM: 614260; ClinVar: pathogenic/likely pathogenic variants

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 20.1 High
Lung 12.3 Medium
Liver 8.5 Medium
Kidney 7.2 Low
Testis 5.0 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.0 Neuronal model
HeLa (cervical carcinoma) 10.2 Epithelial
HepG2 (hepatocellular carcinoma) 8.0 Liver
A549 (lung carcinoma) 7.5 Lung
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
GGGGCC repeat expansion (intron 1) Repeat expansion (typically >30 repeats) Most common genetic cause of ALS/FTD (up to 40% familial cases) Loss of function (reduced C9orf72 protein) and gain of function (toxic RNA foci and dipeptide repeat proteins)
c.415G>A (p.Ala139Thr) Missense Rare Uncertain significance; possibly pathogenic
c.463C>T (p.Arg155*) Nonsense Rare Loss of function; likely pathogenic
Mutation functional classification

Loss of Function (LOF)

Repeat expansion reduces C9orf72 protein expression, impairing autophagy and endosomal trafficking, contributing to neurodegeneration.

Gain of Function (GOF)

Repeat expansion produces toxic RNA foci that sequester RNA-binding proteins and generate dipeptide repeat proteins (DPRs) via repeat-associated non-ATG (RAN) translation, causing cellular toxicity.

Dominant Negative (DN)

Not clearly established; no evidence of dominant-negative effects for C9orf72 mutations.

Gene Ontology (GO)

• protein binding • guanine nucleotide exchange factor activity
• autophagy • endosomal transport
• regulation of GTPase activity

Pathways

Autophagy
Endosomal trafficking
Nucleocytoplasmic transport
Stress granule dynamics

Protein Summary

The C9orf72 protein is a 481-amino acid protein with a DENN domain, suggesting a role in membrane trafficking and Rab GTPase regulation. It is involved in autophagy and endosomal pathways, critical for neuronal health. Loss of function due to repeat expansion impairs these processes, while gain-of-function toxic species exacerbate neurodegeneration.

Related Products

Product name Cat.No. Species Gene ID
C9orf72 Knockout HEK293 Cell Line EDJ-KQ5467 Human 203228 Details Get a Quote
C9orf72 Knockout HeLa Cell Line EDJ-KQ17944 Human 203228 Details Get a Quote
C9orf72 Knockout A-549 Cell Line EDJ-KQ28669 Human 203228 Details Get a Quote
C9orf72 Knockout HCT 116 Cell Line EDJ-KQ28670 Human 203228 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: